3 結果
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of cancer treatment and chemotherapy. More particularly, it concerns use of the protein kinase C (PKC) inhibitor chelerythrine to treat cancer in combination with DNA damaging chemicals to
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of cancer treatment and radiation therapy. More particularly, it concerns a combination of low doses of the protein kinase C (PKC) inhibitor chelerythrine with low doses of ionizing radiation
BACKGROUND OF THE INVENTION
The present invention relates to the treatment of human melanoma, basal and squamous cell skin cancer, and a variety of other skin tumors and skin diseases. More particularly, the present invention relates to unit dose packaging of a zinc chloride mixture and used in a